Bovine lactoferricin induces caspase-independent apoptosis in human B-lymphoma cells and extends the survival of immune-deficient mice bearing B-lymphoma xenografts

Experimental and Molecular Pathology

Volumn 88, Issue 3, 2010, Pages 371-375

  Furlong, Suzanne J ^a   Mader, Jamie S ^a   Hoskin, David W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Apoptosis; B cell lymphoma; Bovine lactoferricin

Indexed keywords

CASPASE; LACTOFERRICIN B; ANTIMICROBIAL CATIONIC PEPTIDE; ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; CASP3 PROTEIN, HUMAN; CASPASE 3; LACTOFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MOUSE; NONHUMAN; SCID MOUSE; SURVIVAL TIME; TUMOR XENOGRAFT; AMINO ACID SEQUENCE; ANIMAL; CANCER TRANSPLANTATION; CATTLE; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

BOVINAE; MUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CATTLE; CELL LINE, TUMOR; CULTURE MEDIA; HUMANS; LACTOFERRIN; LYMPHOMA, B-CELL; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; SERUM ALBUMIN, BOVINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 77952573591     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.02.001     Document Type: Article

References (17)

1. Avivi I., Robinson S., Goldstone A. Clinical use of rituximab in haematological malignancies. Br. J. Cancer 2003, 89:1389-1394.
2. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1992, 1121:130-136.
3. Constantinou C., Papas K.A., Constantinou A.I. Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy?. Curr. Cancer Drug Targets 2009, 9:717-728.
4. Eliassen L.T., Berge G., Leknessund A., Wikman M., Lindin I., Løkke C., Ponthan F., Johnsen J.I., Sveinbjørnsson B., Kogner P., Flaegstad T., Rekdal Ø. The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. Int. J. Cancer 2006, 119:493-500.
5. Furlong S.J., Mader J.S., Hoskin D.W. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide and tamoxifen. Oncol. Rep. 2006, 15:1385-1390.
6. Hoskin D.W., Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta 2008, 1778:357-385.
7. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58:71-96.
8. Mader J.S., Salsman J., Conrad D.M., Hoskin D.W. Bovine lactoferricin induces apoptosis in human leukemia and carcinoma cell lines. Mol. Cancer Ther. 2005, 4:612-624.
9. Mader J.S., Richardson A., Salsman J., Top D., de Antueno R., Duncan R., Hoskin D.W. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria. Exp. Cell Res. 2007, 313:2634-2650.
10. Matzinger P. The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Meth. 1991, 145:185-195.
11. Richardson A., de Antueno R., Duncan R., Hoskin D.W. Intracellular delivery of bovine lactoferricin's antimicrobial core (RRWQWR) kills T-leukemia cells. Biochem. Biophys. Res. Commun. 2009, 388:736-741.
12. Schibli D.J., Hwang P.M., Vogel H.J. The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. FEBS Lett. 1999, 446:213-217.
13. Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9:231-241.
14. Vogel H.J., Schibli D.J., Jing W., Lohmeier-Vogel E.M., Epand R.F., Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 2002, 80:49-63.
15. Yan J.S., Chen X.Y., Li W.P., Yang Y., Song Z.L. Establishing SCID mouse models of B-cell non-Hodgkin's lymphoma. Chin. J. Cancer 2009, 28:181-183.
16. Yoo Y.-C., Watanabe R., Koike Y., Mitobe M., Shimazaki K., Watanabe S., Azuma I. Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species. Biochem. Biophys. Res. Commun. 1997, 237:624-628.
17. Yoshida M., Rybak R.J., Choi Y., Greenberg S.J., Barcos M., Kawata A., Matsuno F., Tsai H., Seon B.K. Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assay. Cancer Res. 1997, 57:678-685.